These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25184310)

  • 1. Recent developments in drug therapy for aplastic anemia.
    Willis L; Rexwinkle A; Bryan J; Kadia TM
    Ann Pharmacother; 2014 Nov; 48(11):1469-78. PubMed ID: 25184310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence.
    Li X; Shangguan X; Wang H; Wang Q; Zhang Y; Han B; Liu R; Zhang F; Fu R; Lin Z; Miao M; Ma X; Lei M; Wu D; Liu L
    Ann Hematol; 2024 Sep; 103(9):3483-3491. PubMed ID: 39088061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive therapy (IST) in adult patients with acquired aplastic anemia (AA): A single-center experience over the past 15 years.
    Alashkar F; Oelmüller M; Herich-Terhürne D; Turki AT; Schmitz C; Vance C; Dührsen U; Röth A
    Eur J Haematol; 2019 Jul; 103(1):18-25. PubMed ID: 30977158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eltrombopag for the treatment of aplastic anemia: current perspectives.
    Lum SH; Grainger JD
    Drug Des Devel Ther; 2016; 10():2833-2843. PubMed ID: 27695288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies in the treatment of aplastic anemia.
    Gómez-Almaguer D; Jaime-Pérez JC; Ruiz-Arguelles GJ
    Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):99-106. PubMed ID: 22307362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances and Long-Term Results of Medical Treatment of Acquired Aplastic Anemia: Are Patients Cured?
    Scheinberg P
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):609-618. PubMed ID: 30047414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series.
    Martynova A; Chiu V; Mert M; Hermel D; Weitz IC
    Ann Hematol; 2021 Apr; 100(4):933-939. PubMed ID: 33420879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia.
    Sakamoto T; Obara N; Maruyama Y; Kato T; Kurita N; Hattori K; Suehara Y; Nishikii H; Yokoyama Y; Sakata-Yanagimoto M; Usuki K; Chiba S
    Eur J Haematol; 2023 Nov; 111(5):768-776. PubMed ID: 37549934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party.
    Marsh JC; Bacigalupo A; Schrezenmeier H; Tichelli A; Risitano AM; Passweg JR; Killick SB; Warren AJ; Foukaneli T; Aljurf M; Al-Zahrani HA; Höchsmann B; Schafhausen P; Roth A; Franzke A; Brummendorf TH; Dufour C; Oneto R; Sedgwick P; Barrois A; Kordasti S; Elebute MO; Mufti GJ; Socie G;
    Blood; 2012 Jun; 119(23):5391-6. PubMed ID: 22544699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eltrombopag in Combination with Rabbit Anti-thymocyte Globulin/Cyclosporine A in Immunosuppressive Therapy-naïve Patients with Aplastic Anemia in Japan.
    Imada K; Obara N; Iida H; Imajo K; Maeda T; Usuki K; Fanghong Z; Hombo Y; Tajima T; Kumagai A; Matsuda A; Nakao S
    Intern Med; 2021 Apr; 60(8):1159-1168. PubMed ID: 33229810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.
    Peffault de Latour R; Kulasekararaj A; Iacobelli S; Terwel SR; Cook R; Griffin M; Halkes CJM; Recher C; Barraco F; Forcade E; Vallejo JC; Drexler B; Mear JB; Smith AE; Angelucci E; Raymakers RAP; de Groot MR; Daguindau E; Nur E; Barcellini W; Russell NH; Terriou L; Iori AP; La Rocca U; Sureda A; Sánchez-Ortega I; Xicoy B; Jarque I; Cavenagh J; Sicre de Fontbrune F; Marotta S; Munir T; Tjon JML; Tavitian S; Praire A; Clement L; Rabian F; Marano L; Hill A; Palmisani E; Muus P; Cacace F; Frieri C; van Lint MT; Passweg JR; Marsh JCW; Socié G; Mufti GJ; Dufour C; Risitano AM;
    N Engl J Med; 2022 Jan; 386(1):11-23. PubMed ID: 34986284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early intensified intravenous cyclosporine therapy predicts favorable response to immunosuppressive therapy with rabbit antithymocyte globulin in patients with severe aplastic anemia.
    Song MK; Chung JS; Joo YD; Lee GW; Hong J; Park SH; Shin HJ
    Leuk Res; 2015 Mar; 39(3):284-9. PubMed ID: 25563075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of eltrombopag in aplastic anemia: A multi-center survey in China].
    Yang WR; Han B; Chang H; Wu BY; Meng FK; Ji DX; Li YM; Zheng ZJ; Fei Y; Shen JP; Hu P; Ding XQ; Zhang P; Wang YQ; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):890-895. PubMed ID: 33333690
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of the refractory aplastic anemia patient: what are the options?
    Marsh JC; Kulasekararaj AG
    Hematology Am Soc Hematol Educ Program; 2013; 2013():87-94. PubMed ID: 24319168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of eltrombopag in the first-line therapy of severe aplastic anemia in children.
    Jie M; Fu L; Li S; He Y; Yao J; Cheng X; Zhang L; Zheng J; Zhang R; Wu R
    Pediatr Hematol Oncol; 2021 Oct; 38(7):647-657. PubMed ID: 33798022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of combination therapy with anti-thymocyte globulin and cyclosporine A as a first-line treatment in adult patients with aplastic anemia: a comparison of rabbit and horse formulations.
    Suzuki T; Kobayashi H; Kawasaki Y; Okazuka K; Hatano K; Fujiwara S; Oh I; Ohmine K; Kanda Y
    Int J Hematol; 2016 Oct; 104(4):446-53. PubMed ID: 27338268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eltrombopag added to immunosuppression for children with treatment-naïve severe aplastic anaemia.
    Groarke EM; Patel BA; Gutierrez-Rodrigues F; Rios O; Lotter J; Baldoni D; St Pierre A; Shalhoub R; Wu CO; Townsley DM; Young NS
    Br J Haematol; 2021 Feb; 192(3):605-614. PubMed ID: 33410523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis.
    Vallejo C; Montesinos P; Polo M; Cuevas B; Morado M; Rosell A; Xicoy B; Díez JL; Salamero O; Cedillo Á; Martínez P; Rayón C;
    Ann Hematol; 2015 Jun; 94(6):947-54. PubMed ID: 25672649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia.
    Peffault de Latour R; Tabrizi R; Marcais A; Leblanc T; Lamy T; Mohty M; Tavitian S; Jubert C; Pasquet M; Galambrun C; Nguyen S; Cahn JY; Braun T; Deconinck E; Bay JO; Sicre de Fontbrune F; Barraco F; Socié G
    Am J Hematol; 2018 May; 93(5):635-642. PubMed ID: 29377260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response To Immunosuppressive Therapy In Patients Of Acquired Aplastic Anaemia: A Single Center Experience From A Developing Country.
    Khan M; Iftikhar R; Chaudhry QU; Mehmood SK; Faraz T; Ghafoor T; Shahbaz N; Khan MA; Shamshad GU; Khattak TA
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S969-S973. PubMed ID: 36550655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.